Clinical Trial Update: Goal Directed Propofol Sedation With Magnesium Sulphate Versus Dexmedetomidine for ERCP Procedure [Phase 3]

View source ↗

Summary

Phase 3 trial updating sedation methods for ERCP comparing goal-directed propofol sedation with magnesium sulfate to dexmedetomidine, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lack of Drug Action

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)
• Magnesium sulfate (magnesium sulfate)
• PROPOFOL (Propofol)

Snippet

Sponsor: Theodor Bilharz Research Institute | Conditions: Lack of Drug Action | Phase 3 | Status: COMPLETED